S5329 When Common Diagnoses Overshadow the Rare: A Case Revealed by EUS After Multiple Admission
Introduction: Chronic diarrhea is a common complaint with a broad differential diagnosis, often attributed to infections, medications, or inflammatory conditions. Rarely, it may signal an underlying neuroendocrine tumor such as a VIPoma—a pancreatic tumor that secretes vasoactive intestinal polypeptide and causes watery diarrhea, hypokalemia, and achlorhydria (WDHA syndrome). Due to its rarity and nonspecific presentation, VIPoma is often misdiagnosed. We present a case of a 61-year-old woman with 2 years of unexplained diarrhea and recurrent hypokalemia, ultimately diagnosed with a pancreatic VIPoma after extensive evaluation. Case Description: A 61-year-old woman with a medical history of hypertension, type 2 diabetes, microscopic colitis, hyperlipidemia, and obesity presented with chronic diarrhea lasting 2 years. Her symptoms included frequent, clear, odorless stools, weakness, and muscle cramps. Despite multiple hospitalizations for hypokalemia and diarrhea, initially attributed to gastroenteritis, Ozempic side effects, or microscopic colitis, her condition persisted. On this admission, stool analysis was negative for pathogens, and a CT scan revealed a fluid-filled colon with pneumobilia. Gastroenterology consultation led to an endoscopic ultrasound (EUS), which identified a 9 mm × 7 mm mass in the uncinate process of the pancreas. A biopsy confirmed a grade 1 VIPoma, and her serum vasoactive intestinal polypeptide (VIP) levels were elevated at 280 pg/ml. Discussion: This case emphasizes the diagnostic challenge of VIPomas in patients with chronic diarrhea and hypokalemia, particularly when more common causes have been excluded. Early identification through advanced imaging like EUS and appropriate treatment with cryoablation and octreotide led to a favorable outcome. This case underscores the need for clinicians to maintain a high index of suspicion for rare endocrine tumors in such patients, as timely diagnosis and intervention can significantly improve prognosis.
Authors
- Abdelwahap Elghezewi
- Wesam Frandah (ORCID: https://orcid.org/0000-0001-8068-7030)
- Abdallah Hussein (ORCID: https://orcid.org/0000-0002-2408-2691)
- Bassel Dakkak
- Ibrahim Shanti
- Ahmed Sherif
Publication Details
- Journal
- The American Journal of Gastroenterology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.14309/01.ajg.0001148776.87495.eb
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00